Augmedix is a technology-enabled service platform that simplifies how physicians work and deal with patients and medical documentation, with physician-wearable technology.


Augmedix is an artificial intelligence-powered service platform that assists physicians and medical care providers with electronic health record-keeping. Augmedix can be integrated with smartphone applications and Google glass, smart glasses developed by the technology company Google, which allow doctors and other care providers to view patient charts and records without having to access a computer.

Google Glass wearable provided by Augmedix

Augmedix works by allowing remote electronic health record (EHR) specialists to observe provider and patient interactions through a smartphone interface or Google Glass. Remote EHR specialists use AI and natural language processing (NLP) speech-to-text to transcribe a patient visit. The Augmedix program also allows the EHR specialist to choose from automated sentences to increase transcription efficacy. After the notation is complete, the AI automates and prioritizes the data to provide organization and structure to the medical chart, and the chart is then uploaded to the hospital's EHR system for provider signature.

Augmedix's product is challenged by the problem of context. Natural language processing is not always able to interpret context, and the algorithms used by Augmedix rely on proximity to identify phrases in a conversation that relate to the same topic This heuristic is not always capable of distinguishing contextual conversation–such as a discussion of low-probability diagnoses being tested for ruling out, versus a potential diagnosis being discussed at the same time. Another can be the use of the pronoun "it" during a discussion or use of a pointing gesture that a human physician can interpret but Augmedix's natural language processing and artificial intelligence cannot necessarily understand.

To help with these challenges, Augmedix uses human input in the form of scribes to do much of the contextual understanding and heavy lifting work while the company develops their natural language processing algorithms for increasing efficiency.

Augmedix is also working to develop their service so it is able to be used on all augmented reality technology and not just Google Glass. These ideas extend to developing their service on more than a single natural language processing program for similar reasons.

Reverse merger and public announcement

Augmedix went public during a reverse merger with Malo Holdings, a former Augmedix subsidiary, on October 5, 2020. Malo Holdings was a Florida-based company focused on providing commercial support services in the industrial industry. As a part of the merger deal, $25 million was given for private placement.


January 14, 2021
Augmedix launches tech-enabled service within emergency departments to Provide real-time support and optimize clinician workflows.

November 16, 2020
Augmedix announces new Chief Technology Officer, Saurav Chatterjee, PhD.
October 22, 2020
Augmedix, a remote scribe services company, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.

To date, it has raised more than $107 million in funding, according to an SEC filing outlining the deal.

October 5, 2020
Augmedix was founded by Ian Shakil and Pelu Tran.
January 22, 2020
Today, Augmedix announced that Joe Marks, Executive Director of the Center for Machine Learning & Health at Carnegie Mellon University, has joined the Augmedix team as the newest board of directors member.

He has run the highly acclaimed research labs at both Mitsubishi Electric and The Walt Disney Company, each with annual budgets exceeding $100M. He has worked on DARPA-sponsored research projects for the US government, co-founded two start-ups, and has served as an advisor and consultant to the American Medical Association--all in addition to his current work at Carnegie Mellon.

October 25, 2019
Augmedix's device-based remote scribing system announces $19M Series B

Augmedix, a startup that uses natural language processing (NLP) and devices to populate medical documentation from clinician-patient conversations, has raised $19 million in Series B funding. Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and other unnamed investors all contributed.

October 24, 2019
Augmedix raises a $17,000,000 venture round from Catholic Health Initiatives, DCM Ventures, Dignity Health, Emergence Capital Partners, Evan Rachlin, Peter Hudson, Redmile Group, Sutter Health and TriHealth.
October 3, 2019
McKesson and Augmedix expand collaboration to enhance the doctor-patient relationship
October 2019
Augmedix raises a $19,000,000 series B round from DCM Ventures, McKesson Ventures, Redmile Group and Wanxiang America Healthcare Investments.
December 6, 2018
Augmedix's EHR documentation platform enters innovative pilot with award-winning iKnowMed Oncology EHR
Page 1 of 2

Funding rounds



Ann Waldo


Ian Shakil

Founder & Chief Strategy Officer

Jonathan Hawkins

Chief Revenue Officer

Further reading


Augmedix Uses AI and Remote Scribes to Improve Clinician Documentation: Interview with Founder Ian Shakil | Medgadget

Cici Zhou


March 11, 2020

Google Glass-powered medical scribe service going public as part of reverse merger deal

Heather Landi


October 21, 2020

SEC filing for public trading of Augmedix.


October 9, 2020

The Challenges of Developing a Digital Scribe - Augmedix


September 21, 2020

To free doctors from computers, far-flung scribes are taking notes

Sarah Kwon


October 4, 2020

Documentaries, videos and podcasts


Augmedix - Montage

March 18, 2014

Augmedix | Phone & Glass Services

September 27, 2019

Augmedix Story: Dignity Health

April 25, 2016

Augmedix Story: Sutter Health

July 18, 2017




January 14, 2021
/PRNewswire/ -- Augmedix, a leading provider of remote medical documentation and live clinical support, is announcing a national rollout of a transformative...
November 17, 2020
/PRNewswire/ -- Augmedix, Inc., the ambient, mobile, real-time, and remote documentation specialist for doctors and health systems, yesterday announced...
November 16, 2020
Augmedix today announced that Saurav Chatterjee has been hired by Augmedix as Chief Technology Officer.
November 16, 2020
/PRNewswire/ -- Augmedix today announced that Saurav Chatterjee has been hired by Augmedix as Chief Technology Officer. Saurav Chatterjee is well-versed in...
Heather Landi
October 21, 2020
As part of a new trend in 2020, a third healthcare technology company is going public through a "blank check" merger. Augmedix recently secured $25 million in private placement financing and completed a reverse merger with Malo Holdings. Here are some details about the company's operations and financial performance.


Page 1 of 2
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.